1+ week, 5+ day ago   (1476+ words) Eventually, however, many patients reach a point at which endocrine-based strategies have been exhausted and chemotherapy becomes necessary. That is the setting in which izalontamab brengitecan (iza-bren; BL-B01D1) is now generating considerable interest. On August 26, 2026, Sichuan Biokin Pharmaceutical announced that…...

2+ week, 6+ day ago   (225+ words) Muna Al-Khaifi, GP oncologist at Mount Sinai Hospital (Toronto), Sinai Health, shared on LinkedIn: “I’m very proud of my summer research student, Jashmira Bhinder, who won First Place in the Poster Presentation at the Osler Research Institute Summer Student Research…...

3+ week, 4+ day ago   (93+ words) Sara Tolaney Leads Study on Breast Cancer Patients With Response After Chemo With Pembrolizumab Oncodaily Sara Tolaney Leads Study on Breast Cancer Patients With Response After Chemo With Pembrolizumab Alliance for Clinical Trials in Oncology shared on X: “Sara Tolaney of…...

3+ week, 5+ day ago   (101+ words) Golnaz Zaeri: Iranian Society of Clinical Oncology to Host HER2-Positive Breast Cancer Tumor Board oncodaily.com Golnaz Zaeri: Iranian Society of Clinical Oncology to Host HER2-Positive Breast Cancer Tumor Board Golnaz Zaeri, Project Coordinator at Iranian Society of Clinical Oncology,…...

1+ mon, 1+ day ago   (250+ words) Ada Waks: Therapeutic Strategy for CDK4/6i-Resistant HR+ Metastatic Breast Cancer / Ada Waks, Adrienne G. Waks, Amy Williams, Ann Partridge, Anna Mae Frey,, Ada Waks, Adrienne G. Waks, Amy Williams, Ann Partridge, Anna Mae Frey, Ashka Patel, Barbara LeStage, Breast Cancer, cancer, Dana-Farber’s…...

1+ mon, 2+ week ago   (97+ words) Tedros Adhanom Ghebreyesus: 80 Years Strong - The WHO Constitution Monica Bertagnolli: Why the National Academy of Medicine Is Needed More Today Than Ever? Éléonore Caroit։ Gustave Roussy International Egypt Center Becomes a Reference Centre for Oncology Care Don S. Dizon: Sometimes…...

1+ mon, 2+ week ago   (187+ words) Breast Cancer Canada and McPeak-Sirois Group Innovative Breast Cancer Clinical Trials Championship 2026 Oncodaily Breast Cancer Canada and McPeak-Sirois Group Innovative Breast Cancer Clinical Trials Championship 2026 Breast Cancer Canada and the McPeak-Sirois Group are offering a national award recognizing innovative investigator-initiated…...

1+ mon, 2+ week ago   (53+ words) Nishant Tiwari, Chief Hematology and Oncology Fellow at OU Health Stephenson Cancer Center, shared on X: “Neoadjuvant Rx for ER+/HER2- Breast Cancer. Educational points, not medical advice. Open for feedback and corrections!” You may also find this interesting: CDK2 Inhibition in CDK4/6 – Resistant…...

1+ mon, 2+ week ago   (800+ words) CDK4/6 inhibitors have reshaped the treatment of ER-positive disease, but most patients with metastatic breast cancer eventually progress. The central question is no longer only how to use CDK4/6 inhibitors in the first line, but how to treat tumors once they have…...

1+ mon, 3+ week ago   (203+ words) Breast Cancer Canada and AstraZeneca Canada Advancing Progress in Survivorship Award 2026 Oncodaily Breast Cancer Canada and AstraZeneca Canada Advancing Progress in Survivorship Award 2026 Breast Cancer Canada, in partnership with AstraZeneca Canada, is offering two matched research awards for Canadian-led projects…...